HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatioN: The HEMOTION Trial
Key facts
- Who runs it
- CHU de Quebec-Universite Laval
- Where
- Brazil, Canada, France, and United Kingdom33 sites in 4 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 742 people enrolled
- Started
- 31 Aug 2017
- Ended
- 16 Feb 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- Red Blood Cells Transfusion
- Record updated
- 3 May 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Acute moderate to severe blunt TBI
- Glasgow Coma Score [GCS] ≤ 12
- Hb level ≤ 100 g/L
Who cannot take part
- Patient has received transfusion after ICU admission
- A decision to withold or withdraw life-sustaining therapies was made
- Active life-threatening bleeding with hemorrhagic shock or requiring urgent surgical procedure
- Contraindications or known objection to transfusions
- Glasgow Coma Scale (GCS) of 3 with dilated fixed pupils
- Patient is brain dead
- No fixed address
This trial has no sites in United States.
It has sites in 4 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
Most trauma deaths are related to traumatic brain injury (TBI). Although the management of patients has improved, mortality remains unacceptably high, and half of survivors of moderate and severe TBI are left with major functional impairment. Current management guidelines are based on limited evidence and practice is highly variable. Most acutely ill patients with TBI will develop anemia, which may decrease oxygen delivery to a fragile brain. While clinical practice is moving towards transfusing at low hemoglobin (Hb) levels, experts have expressed concerns regarding restrictive strategies, which may adversely affect clinical outcomes in TBI. Our primary objective is to evaluate the effect of red blood cell (RBC) transfusion thresholds on neurological functional outcome. We hypothesize that a liberal transfusion strategy improves outcomes compared to a restrictive strategy.
The 2 groups in the trial
- Liberal Transfusion StrategyTreatment being tested
Patients will receive red blood cells transfusion if Hb ≤ 100 g/L.
Treatment: Red Blood Cells Transfusion
- Restrictive Transfusion StrategyTreatment being tested
Patients will receive red blood cells transfusion if Hb ≤ 70 g/L.
Treatment: Red Blood Cells Transfusion
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Liberal or Restrictive Transfusion Strategy in Patients with Traumatic Brain Injury.The New England journal of medicine, 2024
- Haemoglobin transfusion threshold in traumatic brain injury optimisation (HEMOTION): a multicentre, randomised, clinical trial protocol.BMJ open, 2022
- Record updated
- 3 May 2024